secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001193125-25-314430
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics prices public offering of 6.14M shares at $42.50, raising ~$260.9M
--------------------------------------------------------------------------------

- Entered underwriting agreement Dec 9 to sell 6,138,108 shares of common stock at $42.50/share.
- Gross proceeds to company approximately $260.9 million before underwriting discounts and expenses.
- Underwriters fully exercised 30-day over-allotment option for 920,716 additional shares on Dec 10.
- Offering expected to close Dec 11, 2025, subject to customary conditions.
- Shares offered under existing automatic shelf registration statement (File No. 333-282861).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525314430/0001193125-25-314430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525314430/d870139d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-314430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer